Sartorius (OTCMKTS:SARTF) AG, trading as SARTF on the OTCMKTS, is a leading international supplier of laboratory and bioprocessing equipment for the life sciences sector. Founded in 1870 in Göttingen, Germany, the company has evolved from a manufacturer of precision weighing scales into a diversified provider of products and services that support research and production in the biopharmaceutical industry.
The company operates through two main business divisions. The Bioprocess Solutions segment offers technologies for the filtration, fermentation and purification of biological drugs, including single-use bioreactors, chromatography systems and membrane filtration devices. The Lab Products & Services unit supplies laboratory instruments such as analytical balances, pipettes, cell counters and consumables, alongside software and services that enhance workflow efficiency and data integrity in research laboratories.
Sartorius maintains a global network of research and manufacturing facilities across Europe, North America, Asia and Latin America. Its products are used by pharmaceutical and biotech companies, academic research institutes and contract development and manufacturing organizations (CDMOs). The company emphasizes close collaboration with customers to tailor solutions for process scale-up, quality control and regulatory compliance.
Under the leadership of a seasoned executive board headed by chief executive officer Dr. Joachim Kreuzburg, Sartorius continues to invest in innovation, digitalization and sustainability initiatives. The company focuses on expanding its single-use technology portfolio and enhancing automation capabilities to meet growing demand for biologics and advanced therapies worldwide.
